Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filgrastim”

397 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 397 results

Testing effectiveness (Phase 2)Study completedNCT00002501
What this trial is testing

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 29
Not applicableStudy completedNCT02322151
What this trial is testing

Pharmacokinetics of Granulocyte Colony Stimulating Factor in the Breast Milk of Volunteer Peripheral Blood Stem Cell Donor

Who this might be right for
Normal Physiology
National Institutes of Health Clinical Center (CC) 4
Large-scale testing (Phase 3)Study completedNCT00083876
What this trial is testing

D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 500
Early research (Phase 1)Study completedNCT02923791
What this trial is testing

A Study in Healthy Volunteers to Assess Immune Response to Multiple Injections of Filgrastim Hospira or Neupogen Reference Product.

Who this might be right for
Healthy Volunteers
Pfizer 256
Testing effectiveness (Phase 2)Study completedNCT01538862
What this trial is testing

Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Vanderbilt University Medical Center 7
Not applicableStudy completedNCT01574235
What this trial is testing

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Who this might be right for
Solid TumorsMalignant HemopathyChemotherapy-induced Febrile Neutropenia (FN)
Hospira, now a wholly owned subsidiary of Pfizer 2,114
Testing effectiveness (Phase 2)UnknownNCT00006215
What this trial is testing

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Amgen
Testing effectiveness (Phase 2)Study completedNCT00005985
What this trial is testing

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Masonic Cancer Center, University of Minnesota 213
Testing effectiveness (Phase 2)Study completedNCT00025545
What this trial is testing

Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)UnknownNCT05881382
What this trial is testing

Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction

Who this might be right for
ST Elevation Myocardial Infarction
Recardio, Inc. 4,100
Testing effectiveness (Phase 2)Study completedNCT00000626
What this trial is testing

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Who this might be right for
HIV InfectionsHodgkin's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 27
Early research (Phase 1)Study completedNCT00004189
What this trial is testing

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)UnknownNCT00559221
What this trial is testing

FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML

Who this might be right for
Acute Myeloid Leukemia
Cooperative Study Group A for Hematology 37
Testing effectiveness (Phase 2)Ended earlyNCT01658904
What this trial is testing

Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma

Who this might be right for
Multiple MyelomaLeukemia, Plasma Cell
National Cancer Institute (NCI) 3
Not applicableUnknownNCT03498248
What this trial is testing

Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)

Who this might be right for
Neutropenia
DERSHENG SUN 155
Testing effectiveness (Phase 2)WithdrawnNCT00446173
What this trial is testing

Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00008125
What this trial is testing

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Pittsburgh 25
Early research (Phase 1)Study completedNCT01031368
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+15 more
Nohla Therapeutics, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00117897
What this trial is testing

Treatment for Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Large-scale testing (Phase 3)UnknownNCT03665480
What this trial is testing

The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML

Who this might be right for
Granulocyte Colony-stimulating FactorMinimal Residual DiseaseAcute Myeloid Leukemia
Nanfang Hospital, Southern Medical University 122
Next Page